Another Study Shows: Antipsychotic Trials Biased Towards Sponsor’s Drug
An independent review by a team of German analysts published in the American Journal of Psychiatry confirms that corporate bias is ubiquitous in clinical trials.
An independent review by a team of German analysts published in the American Journal of Psychiatry confirms that corporate bias is ubiquitous in clinical trials.
"modern pharmacological treatment may be no more beneficial than older ones, despite their added cost."
"This is a critical moment: if the system of peer-review is not any longer able to guarantee the reliability of scientific research, this means that science has lost its way."
“Science has become so severely politicized that one has to be skeptical of nearly every research result that is reported.”
A critical examination of meta-analysis studies by John H. Noble, Jr, Ph.D, AHRP Treasurer